Categories: Health Care

Torrent Pharma enters into licensing agreement with Medicine Patent Pool to manufacture and commercialise generic version of Pfizer Oral COVID-19 Treatment

New Delhi, March 20, 2022: Torrent Pharmaceuticals Limited (herein after referred to as “TPL”) has announced that it has signed a non-exclusive, non-transferable, non-sub licensable, license agreement to use the patents and know-how in relation to the compound nirmatrelvir with Medicine Patent Pool (herein after referred to as “MPP”) for manufacture and commercialisation of the generic version of PAXLOVID™ [product containing the compound nirmatrelvir (PF-07321332) to be co-packaged and co-administered with ritonavir] in 95 low and middle income countries including India for treatment and/or prevention of COVID-19 caused by SARS- CoV-2.

Earlier, MPP had entered into license agreement with PF Prism Holdings B.V. (Pfizer) granting MPP with the rights to sub-license manufacture and commercialisation rights to sub-licensees.

The oral COVID-19 treatment comprises of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating and ritonavir, which slows down nirmatrelvir’s breakdown to help it remain in the body for a longer period at higher concentrations.

TPL will launch the product after obtaining necessary approval from Regulatory Agencies.

Pfizer markets its oral COVID-19 treatment under the name PAXLOVID™, which is authorized by U.S. Food and Drug Administration (FDA) [for Emergency Use Authorisation (EUA)] and the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of COVID-19 in patients at high-risk of progressing to serious illness.

Commenting on the arrangement, Aman Mehta (Executive Director) said: “We are pleased to enter into this agreement with MPP and is part of our continued endeavor to make Covid treatments as accessible as possible to patients.”

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Lung Cancer Awareness Month

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

4 hours ago

Unmasking COPD: The Silent Respiratory Threat of Smoking

By  Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital …

4 hours ago

Khazi India Foundation to Host Expert Cardiac Consultations in Adoni

Kurnool, November 20, 2024: Adoni, Andhra Pradesh, – The Khazi India Foundation is pleased to…

1 day ago

Aakash Healthcare Celebrates Children’s Day with Kids from Choti Si Khushi

New Delhi, November 20, 2024: Aakash Healthcare marked this year’s Children’s Day with a joyful…

1 day ago

Annual eye screening crucial for diabetic patients to protect eyesight: Dr Agarwals Eye Hospital

Dr Agarwals Eye Hospital, Bengaluru, is providing free consultations for diabetic patients aged 50 and…

3 days ago

7 Signs You Are Suffering From Protein Deficiency

By Ms. Archana S, Senior Nutritionist, Aster Whitefield Hospital, Bengaluru As an essential nutrient, protein…

3 days ago